Rhumbline Advisers lifted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 0.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,846,244 shares of the company's stock after buying an additional 4,747 shares during the period. Rhumbline Advisers owned about 0.23% of Colgate-Palmolive worth $167,842,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $32,000. Hager Investment Management Services LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $36,000. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $53,000. Finally, Synergy Asset Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $49,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Raymond James reiterated an "outperform" rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of "Hold" and a consensus price target of $101.16.
Get Our Latest Stock Analysis on CL
Colgate-Palmolive Stock Performance
Shares of CL traded up $0.93 during mid-day trading on Wednesday, hitting $87.32. 4,306,951 shares of the company's stock were exchanged, compared to its average volume of 4,940,192. Colgate-Palmolive has a 52 week low of $83.70 and a 52 week high of $109.30. The stock's 50-day simple moving average is $89.24 and its 200-day simple moving average is $96.11. The firm has a market cap of $70.86 billion, a price-to-earnings ratio of 24.81, a price-to-earnings-growth ratio of 4.10 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the business earned $0.87 EPS. On average, equities research analysts expect that Colgate-Palmolive will post 3.76 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. Colgate-Palmolive's dividend payout ratio (DPR) is 56.82%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.